位置:首页 > 蛋白库 > CARF_MYXXA
CARF_MYXXA
ID   CARF_MYXXA              Reviewed;         281 AA.
AC   Q9AE87;
DT   26-FEB-2020, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   03-AUG-2022, entry version 46.
DE   RecName: Full=Plasmanylethanolamine desaturase {ECO:0000303|PubMed:31604315};
DE            EC=1.14.19.77 {ECO:0000269|PubMed:31604315};
DE   AltName: Full=Carotenogenesis protein CarF {ECO:0000303|PubMed:12519205};
DE            Short=CarF {ECO:0000303|PubMed:12519205};
GN   Name=carF {ECO:0000303|PubMed:12519205};
OS   Myxococcus xanthus.
OC   Bacteria; Proteobacteria; Deltaproteobacteria; Myxococcales;
OC   Cystobacterineae; Myxococcaceae; Myxococcus.
OX   NCBI_TaxID=34;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, DISRUPTION PHENOTYPE, DOMAIN,
RP   AND MUTAGENESIS OF HIS-78; HIS-103; HIS-113 AND HIS-218.
RC   STRAIN=DK1050;
RX   PubMed=12519205; DOI=10.1046/j.1365-2958.2003.03319.x;
RA   Fontes M., Galbis-Martinez L., Murillo F.J.;
RT   "A novel regulatory gene for light-induced carotenoid synthesis in the
RT   bacterium Myxococcus xanthus.";
RL   Mol. Microbiol. 47:561-571(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Hartzell P.L., Youderian P.A.;
RT   "Identification of genes required for adventurous gliding motility in
RT   Myxococcus xanthus with the transposable element mariner.";
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CARR, DOMAIN, MUTAGENESIS
RP   OF HIS-78; HIS-103; HIS-113; HIS-164; HIS-195 AND HIS-218, AND TOPOLOGY.
RC   STRAIN=DK1050;
RX   PubMed=18310035; DOI=10.1099/mic.0.2007/013359-0;
RA   Galbis-Martinez L., Galbis-Martinez M., Murillo F.J., Fontes M.;
RT   "An anti-antisigma factor in the response of the bacterium Myxococcus
RT   xanthus to blue light.";
RL   Microbiology 154:895-904(2008).
RN   [4]
RP   FUNCTION, AND DOMAIN.
RC   STRAIN=DK1050;
RX   PubMed=22267513; DOI=10.1128/jb.06662-11;
RA   Galbis-Martinez M., Padmanabhan S., Murillo F.J., Elias-Arnanz M.;
RT   "CarF mediates signaling by singlet oxygen, generated via photoexcited
RT   protoporphyrin IX, in Myxococcus xanthus light-induced carotenogenesis.";
RL   J. Bacteriol. 194:1427-1436(2012).
RN   [5]
RP   FUNCTION, DOMAIN, MUTAGENESIS OF HIS-78; HIS-103; HIS-104; HIS-113;
RP   HIS-164; HIS-168; HIS-183; HIS-190; HIS-191; HIS-194; HIS-195 AND HIS-218,
RP   AND CATALYTIC ACTIVITY.
RX   PubMed=31604315; DOI=10.1126/science.aay1436;
RA   Gallego-Garcia A., Monera-Girona A.J., Pajares-Martinez E.,
RA   Bastida-Martinez E., Perez-Castano R., Iniesta A.A., Fontes M.,
RA   Padmanabhan S., Elias-Arnanz M.;
RT   "A bacterial light response reveals an orphan desaturase for human
RT   plasmalogen synthesis.";
RL   Science 366:128-132(2019).
CC   -!- FUNCTION: Plasmanylethanolamine desaturase involved in plasmalogen
CC       biogenesis in the membrane, required for light-induced carotenogenesis
CC       (PubMed:12519205, PubMed:18310035, PubMed:22267513, PubMed:31604315).
CC       Plasmalogens are glycerophospholipids with a hydrocarbon chain linked
CC       by a vinyl ether bond at the glycerol sn-1 position, and are involved
CC       in antioxidative and signaling mechanisms, most precisely in sensing
CC       photooxidative stress through singlet oxygen (PubMed:31604315).
CC       Participates in the light-dependent inactivation of the antisigma
CC       factor CarR (PubMed:12519205, PubMed:18310035). Mediates signaling by
CC       singlet oxygen, generated via photoexcited protoporphyrin IX
CC       (PubMed:22267513). {ECO:0000269|PubMed:12519205,
CC       ECO:0000269|PubMed:18310035, ECO:0000269|PubMed:22267513,
CC       ECO:0000269|PubMed:31604315}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(1,2-saturated alkyl)-2-acyl-sn-glycero-3-
CC         phosphoethanolamine + 2 Fe(II)-[cytochrome b5] + 2 H(+) + O2 = 1-O-
CC         (1Z-alkenyl)-2-acyl-sn-glycero-3-phosphoethanolamine + 2 Fe(III)-
CC         [cytochrome b5] + 2 H2O; Xref=Rhea:RHEA:22956, Rhea:RHEA-COMP:10438,
CC         Rhea:RHEA-COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:75028, ChEBI:CHEBI:77290; EC=1.14.19.77;
CC         Evidence={ECO:0000269|PubMed:31604315};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22957;
CC         Evidence={ECO:0000269|PubMed:31604315};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-(13-methyltetradecyl)-2-(13-methyltetradecanoyl)-sn-
CC         glycero-3-phosphoethanolamine + 2 Fe(II)-[cytochrome b5] + 2 H(+) +
CC         O2 = 1-O-(1Z-13-methyltetradecenyl)-2-(13-methyltetradecanoyl)-sn-
CC         glycero-3-phosphoethanolamine + 2 Fe(III)-[cytochrome b5] + 2 H2O;
CC         Xref=Rhea:RHEA:61972, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:145179,
CC         ChEBI:CHEBI:145180; Evidence={ECO:0000269|PubMed:31604315};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61973;
CC         Evidence={ECO:0000269|PubMed:31604315};
CC   -!- SUBUNIT: Interacts with CarR. {ECO:0000269|PubMed:18310035}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane
CC       {ECO:0000305|PubMed:18310035}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- DOMAIN: Histidine box-1 and -2 together with other histidine residues
CC       are essential for catalytic activity. {ECO:0000269|PubMed:12519205,
CC       ECO:0000269|PubMed:18310035, ECO:0000269|PubMed:22267513,
CC       ECO:0000269|PubMed:31604315}.
CC   -!- DISRUPTION PHENOTYPE: Deletion prevents the activation of the light
CC       inducible promoters of carQ, crtI and carB.
CC       {ECO:0000269|PubMed:12519205}.
CC   -!- SIMILARITY: Belongs to the fatty acid desaturase CarF family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY204462; AAO22861.1; -; Genomic_DNA.
DR   EMBL; AJ311657; CAC34626.1; -; Genomic_DNA.
DR   RefSeq; WP_011555701.1; NZ_JABFNQ010000107.1.
DR   AlphaFoldDB; Q9AE87; -.
DR   SwissLipids; SLP:000001974; -.
DR   GeneID; 41362993; -.
DR   OMA; RTQECIC; -.
DR   BioCyc; MetaCyc:MON-21879; -.
DR   BRENDA; 1.14.19.77; 3551.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0050207; F:plasmanylethanolamine desaturase activity; IDA:UniProtKB.
DR   GO; GO:0008611; P:ether lipid biosynthetic process; IDA:UniProtKB.
DR   InterPro; IPR019547; Lipid_desat.
DR   Pfam; PF10520; Lipid_desat; 1.
PE   1: Evidence at protein level;
KW   Cell inner membrane; Cell membrane; Membrane; Oxidoreductase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..281
FT                   /note="Plasmanylethanolamine desaturase"
FT                   /id="PRO_0000448849"
FT   TOPO_DOM        1..28
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:18310035"
FT   TRANSMEM        29..45
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        46..58
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000269|PubMed:18310035"
FT   TRANSMEM        59..75
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        76..123
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:18310035"
FT   TRANSMEM        124..138
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        139..142
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000269|PubMed:18310035"
FT   TRANSMEM        143..159
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        160..281
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:18310035"
FT   MOTIF           164..168
FT                   /note="Histidine box-1"
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   MOTIF           191..195
FT                   /note="Histidine box-2"
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   SITE            78
FT                   /note="Essential for plasmanylethanolamine desaturase
FT                   activity"
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   SITE            103
FT                   /note="Essential for plasmanylethanolamine desaturase
FT                   activity"
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   SITE            104
FT                   /note="Essential for plasmanylethanolamine desaturase
FT                   activity"
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   SITE            113
FT                   /note="Essential for plasmanylethanolamine desaturase
FT                   activity"
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   MUTAGEN         78
FT                   /note="H->A: Impaired carotenoid synthesis caused by loss
FT                   of plasmanylethanolamine desaturase activity."
FT                   /evidence="ECO:0000269|PubMed:12519205,
FT                   ECO:0000269|PubMed:18310035, ECO:0000269|PubMed:31604315"
FT   MUTAGEN         103
FT                   /note="H->A: Impaired carotenoid synthesis caused by loss
FT                   of plasmanylethanolamine desaturase activity."
FT                   /evidence="ECO:0000269|PubMed:12519205,
FT                   ECO:0000269|PubMed:18310035, ECO:0000269|PubMed:31604315"
FT   MUTAGEN         104
FT                   /note="H->A: Impaired carotenoid synthesis caused by loss
FT                   of plasmanylethanolamine desaturase activity."
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   MUTAGEN         113
FT                   /note="H->A: Impaired carotenoid synthesis caused by loss
FT                   of plasmanylethanolamine desaturase activity."
FT                   /evidence="ECO:0000269|PubMed:12519205,
FT                   ECO:0000269|PubMed:18310035, ECO:0000269|PubMed:31604315"
FT   MUTAGEN         164
FT                   /note="H->A: Impaired carotenoid synthesis caused by loss
FT                   of plasmanylethanolamine desaturase activity."
FT                   /evidence="ECO:0000269|PubMed:18310035,
FT                   ECO:0000269|PubMed:31604315"
FT   MUTAGEN         168
FT                   /note="H->A: Impaired carotenoid synthesis caused by loss
FT                   of plasmanylethanolamine desaturase activity."
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   MUTAGEN         183
FT                   /note="H->A: No effect on plasmanylethanolamine desaturase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   MUTAGEN         190
FT                   /note="H->A: No effect on plasmanylethanolamine desaturase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   MUTAGEN         191
FT                   /note="H->A: Impaired carotenoid synthesis caused by loss
FT                   of plasmanylethanolamine desaturase activity."
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   MUTAGEN         194
FT                   /note="H->A: Impaired carotenoid synthesis caused by loss
FT                   of plasmanylethanolamine desaturase activity."
FT                   /evidence="ECO:0000269|PubMed:31604315"
FT   MUTAGEN         195
FT                   /note="H->A: Impaired carotenoid synthesis caused by loss
FT                   of plasmanylethanolamine desaturase activity."
FT                   /evidence="ECO:0000269|PubMed:18310035,
FT                   ECO:0000269|PubMed:31604315"
FT   MUTAGEN         218
FT                   /note="H->A: No effect on plasmanylethanolamine desaturase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:12519205,
FT                   ECO:0000269|PubMed:18310035, ECO:0000269|PubMed:31604315"
SQ   SEQUENCE   281 AA;  31210 MW;  02D4597978D29A0A CRC64;
     MKTQEIEKKV RQQDAQVLAQ GYSPAIRAME IAAIVSFVSL EVALVYRLWG TPYAGTWLLL
     SAVLLGYLAA DFVSGFVHWM GDTWGSTEMP VLGKALIRPF REHHVDEKAI TRHDFVETNG
     NNCLISLPVA IIALCLPMSG PGWVFCASFL GAMIFWVMAT NQFHKWSHMD SPPALVGFLQ
     RVHLILPPDH HRIHHTKPYN KYYCITVGWM NKPLTMVHFF PTAERLITWA TGLLPRQDDI
     GAEAARALVV AAGGSEAPVV QAAKELLTQA TVQEKPASTR P
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024